Glaxo Smith Kline

GSK’S Introduction

GlaxoSmithKline often abbreviated to GSK, is a global

pharmaceutical, biologics, vaccines and consumer

healthcare company headquartered in London, United

Kingdom.

GSK’S Introduction

• It is world’s third largest pharmaceutical company measured by revenues ( after Johnson and Johnson and Pfizer.

• It has a portfolio of products for major disease areas including asthma, cancer, virus control, infections, mental health, diabetes and digestive conditions.

History

• GlaxoSmithKline plc is a public limited company incorporated on 6th December 1999 under English law. Its shares are listed on the London Stock Exchange and the New York Stock Exchange.

• On 27th December 2000 the company acquired Glaxo Wellcome plc and SmithKline Beecham plc, both English public limited companies, by way of a scheme of arrangement for the merger of the two companies.

History

• GSK and its subsidiary and associated undertakings constitute a major global healthcare group engaged in the creation, discovery, development, manufacture and marketing of pharmaceutical and consumer health-related products.

• GSK has its corporate head office in London and has its US headquarters in Research Triangle Park, North Carolina, with operations in some 120 countries, and products sold in over

150 countries.

Chairman:

Sir Christopher Gent

Chief Executive Officer:

Andrew Witty

GSK’s Mission

SIMPLYFY

GROW

DELIVER

MISSIONMISSION

GSK MISSION

GSK’S Mission

Grow a diversified global business – We are diversifying our business to create a more balanced product portfolio and move away from a reliance on traditional ‘white pill/western markets’. We are investing in key growth areas such as Emerging Markets, Japan, Vaccines and our Consumer Healthcare business.

.

GSK’S Mission

Deliver more products of value – We aim to sustain an

industry-leading pipeline of products, ensuring that they

demonstrate value for healthcare providers. Our R&D

strategy is built around focusing on the best science,

diversifying through externalisation of research, and

improving the returns on investment.

GSK’S Mission

Simplify the operating model – GSK is a large and complex organisation. We are transforming our operating model to reduce complexities, improve efficiency and reduce costs

Products

1. Prescription medicines

2. Vaccines

3. Consumer Healthcare

PRESCRIPTION MEDICINES

ALLI-WEIGHT LOSS DRUG

AVANDIA-DIABETIS CONTROL

ROTAVIRUS VACCINE ROTARIX

VACCINE FOR MEASLES

CONSUMER HEALTHCARE PRODUCTS

CONSUMER HEALTHCARE PRODUCTS

Two other companies

• Stiefel, a GSK company— A Global Leader in Dermatology

• ViiV Healthcare —

a global specialist HIV company established by GlaxoSmithKline and Pfizer to deliver advances in treatment and care for people

STIEFEL-A GSK COMPANY

VIIV- HEALTHCARE COMPANY

Turnover ( in billion pounds)2009 28.4

2008 24.4

2007 22.7

2006 23.2

2005 21.7

World market by geographic region

value(billion pounds) % of total• USA 187 40• Europe 131 28• France 25 5• Germany 24 5• Italy 16 3• UK 12 3• Rest of World 150 32• Emerging markets 66 14• Asia Pacific 20 4• Japan 50 11• Canada 11 2

Regional analysis

(2009) (2008) cer% pnd%• USA 9,180 8,894 (13) 3

• Europe 7,681 6,483 9 18

• Emerging Markets 2,973 2,290 20 30

• Asia Pacific/Japan 2,700 1,918 16 41

• Other trading‡ 1,180 796 31 48

23,714 20,381 2 16

• CER% represents growth at constant exchange rates.

• Pound % growth at actual exchange rates.

Consumer Healthcare turnover(million pounds)

(2009) (2008) cer% pound %

Over the counter 2,319 1935 8 20

Medicines

Oral healthcare 1484 1240 7 20

Nutritional healthcare 851 796 3 7

Sales Trend

Five countries chosen

USA

JAPAN

GERMANY

SWITZERLAND

UK

COMPETITORS IN USA

NAME OF THE COMPANY

1. Johnson & Johnson

2. Abbott Laboratories

3. Merck & Co.

4. Eli lilly

5. Bristol-Myers Squibb

• TOTAL REVENUE(IN USD BILLIONS )

• 61.90

• 30.76

• 27.43

• 21.84

• 18.81

JOHNSON &JOHNSON

ABBOT LABORATARIES

MERCK &CO.

ELI LILLY

BRISTOL-MYERS SQUIBB

COMPETITORS IN JAPAN

NAME OF THE COUNTRY

1. TAKEDAPHARMACEUTICAL.

2. ASTELLAS PHARMA

3. DAIICHI SANKYO 9

4. EISAI

5. CHUGAI PHARMACEUTICAL .

TOTAL REVENUE

(IN USD BILLIONS)

• 15.6

• 10.7

• 9

• 5.5

• 2.0

TAKEDA PHARMACEUTICALS

ASTELLAS PHARMA

DAIICHI SANKYO

EISAI

CHUGAI PHARMACEUTICALS

COMPETITORS IN GERMANY

NAME OF THE COUNTRY

1. BAYER

2. BOEHRINGER INGELHEIM

3. MERCK kGaA

TOTAL REVENUE

(IN USD BILLIONS)

• 22.3

• 16.9

• 5.17

BAYER

BOEHRINGER INGELHEIM

MERCK KGAA

COMPETITORS IN SWITZERLAND

NAME OF THE COUNTRY

1. HOFFMAN LA ROCHE

2. NOVARTIS

3. NYCOMED

TOTAL REVENUE

(IN USD BILLIONS)• 47.35

• 44.27

• 4.26

HOFFMAN LA ROCHE

NOVARTIS

NYCOMED

COMPETITORS IN UK

NAMEOF THE COMPANY

• TOTAL REVENUE

(IN USD BILLIONS)

• 45.83

• 32.81

1. GlaxoSmithKline

2. AstraZeneca

ASTRA ZENECA

SUBMITTED BY:ISHDEEP SINGHM100700019